Study of VIS410 in Subjects With Uncomplicated Influenza A
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2a randomized, double-blind, placebo-controlled study designed to assess the
safety and tolerability of VIS410 in subjects with uncomplicated influenza.
Phase:
Phase 2
Details
Lead Sponsor:
Visterra, Inc.
Collaborator:
Biomedical Advanced Research and Development Authority